van Dijk Marcus Antonius 4
4 · MiNK Therapeutics, Inc. · Filed Jan 18, 2024
Insider Transaction Report
Form 4
van Dijk Marcus Antonius
Chief Technology Officer
Transactions
- Award
Stock Option
2024-01-16+171,078→ 171,078 totalExercise: $0.87Exp: 2034-01-16→ Common Stock (171,078 underlying) - Award
Stock Option
2024-01-16+15,000→ 15,000 totalExercise: $0.87Exp: 2034-01-16→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]An option to purchase Common Stock was granted to Dr. van Dijk on January 16, 2024 and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. The option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter.
- [F2]An option to purchase Common Stock was granted to Dr. van Dijk on January 16, 2024 for his performance in 2023, and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. Half of the options will vest on June 27, 2024 and half of the options will vest on September 27, 2024.